Apixaban (Eliquis): Apixaban is an oral anticoagulant used to prevent and treat blood clots, including atrial fibrillation, deep vein thrombosis (DVT), and pulmonary embolism (PE). It is a factor Xa inhibitor.

Arixtra: Arixtra (fondaparinux) is an injectable anticoagulant used to prevent and treat DVT and PE. It is a synthetic pentasaccharide that works as an indirect factor Xa inhibitor.

Coumadin (warfarin): Warfarin is an oral anticoagulant that has been in use for many years. It is used to prevent and treat blood clots, and it works by interfering with the body's blood-clotting process.

Dabigatran (Pradaxa): Dabigatran is an oral anticoagulant used to reduce the risk of stroke and blood clots in patients with atrial fibrillation. It is a direct thrombin inhibitor.

Dalteparin (Fragmin): Dalteparin is an injectable anticoagulant used to prevent and treat DVT and PE. It is a low molecular weight heparin.

Edoxaban (Savaysa): Edoxaban is an oral anticoagulant used to prevent stroke in patients with atrial fibrillation and treat and prevent DVT and PE. It is a factor Xa inhibitor.

Enoxaparin (Lovenox): Enoxaparin is an injectable anticoagulant used to prevent and treat DVT and PE. It is also a low molecular weight heparin.

Heparin: Heparin is an injectable anticoagulant used in various medical settings to prevent and treat blood clots. It works by enhancing the activity of antithrombin, an endogenous anticoagulant.

Rivaroxaban (Xarelto): Rivaroxaban is an oral anticoagulant used to reduce the risk of stroke in atrial fibrillation, as well as to treat and prevent DVT and PE. It is a factor Xa inhibitor.

Bivalirudin (Angiomax): Bivalirudin is an injectable direct thrombin inhibitor used primarily during percutaneous coronary intervention (PCI) procedures and in patients with heparin-induced thrombocytopenia (HIT).

Argatroban: Argatroban is an injectable direct thrombin inhibitor used to prevent or treat thrombosis, particularly in patients with HIT.

Fondaparinux (Arixtra): Fondaparinux, which you already mentioned, is an injectable factor Xa inhibitor used to prevent and treat DVT and PE.

Acenocoumarol (Sintrom): Acenocoumarol is an oral anticoagulant that works similarly to warfarin. It is used to prevent and treat blood clots.

Enoxaparin (Lovenox), which you already mentioned, is a low molecular weight heparin commonly used for DVT and PE prevention and treatment.

Tinzaparin (Innohep): Tinzaparin is another low molecular weight heparin used for the prevention and treatment of DVT and PE.

Daltaparin (Fragmin), which you already mentioned, is another low molecular weight heparin used for DVT and PE prevention and treatment.

Acetylsalicylic Acid (Aspirin): Aspirin is not a typical anticoagulant but is often used in lower doses to prevent blood clots and reduce the risk of heart attacks and strokes.

Nadroparin (Fraxiparine): Nadroparin is another low molecular weight heparin used to prevent and treat DVT and PE.

Heparin (unfractionated heparin), which you already mentioned, is an injectable anticoagulant used in various clinical settings to prevent and treat blood clots.

Desirudin (Iprivask): Desirudin is an injectable direct thrombin inhibitor used to prevent deep vein thrombosis (DVT) in patients undergoing hip replacement surgery.

Danaparoid (Orgaran): Danaparoid is an injectable anticoagulant used to prevent and treat deep vein thrombosis (DVT) and pulmonary embolism (PE). It is often used in patients with heparin-induced thrombocytopenia (HIT).

Anagrelide (Agrylin): Anagrelide is an oral medication that reduces the production of platelets and is used to manage conditions like essential thrombocythemia, where there is an overproduction of platelets.

Ticagrelor (Brilinta): Ticagrelor is an oral antiplatelet medication that inhibits platelet aggregation and is used in patients with acute coronary syndrome and those who have had a heart attack.

Vorapaxar (Zontivity): Vorapaxar is an oral medication used as an antiplatelet agent to reduce the risk of cardiovascular events in patients with a history of heart attack or peripheral artery disease.

Cilostazol (Pletal): Cilostazol is an oral medication that is used to improve the symptoms of intermittent claudication, a condition caused by reduced blood flow to the legs.

Dipyridamole (Persantine): Dipyridamole is an oral medication often used in combination with other antiplatelet agents for conditions such as preventing stroke in patients with a history of transient ischemic attacks (TIAs).

Sulfinpyrazone: Sulfinpyrazone is an oral medication that helps prevent blood clots and is used in conditions like gout and other clotting disorders.

Ticlopidine (Ticlid): Ticlopidine is an oral antiplatelet medication used to reduce the risk of stroke in certain patients, particularly those who have had a previous stroke.

Prasugrel (Effient): Prasugrel is an oral antiplatelet medication used in patients with acute coronary syndrome who are undergoing percutaneous coronary intervention (PCI).

Clopidogrel (Plavix): Clopidogrel is an oral antiplatelet medication commonly prescribed to reduce the risk of heart attack and stroke in patients with cardiovascular disease.

Vorapaxar (Zontivity), which you already mentioned, is an oral antiplatelet agent used to reduce the risk of cardiovascular events in patients with a history of heart attack or peripheral artery disease.

Abciximab (ReoPro): Abciximab is an injectable antiplatelet medication used during coronary angioplasty and stent placement to prevent blood clots.

Eptifibatide (Integrilin): Eptifibatide is an injectable antiplatelet medication used in patients undergoing percutaneous coronary intervention (PCI) to reduce the risk of blood clots.

Tirofiban (Aggrastat): Tirofiban is an injectable antiplatelet medication used in patients undergoing PCI to prevent blood clots in the coronary arteries.

Cangrelor (Kengreal): Cangrelor is an intravenous antiplatelet medication used in patients undergoing PCI to prevent platelet activation and blood clot formation.

Argatroban, which you already mentioned, is an injectable direct thrombin inhibitor used in various clinical settings to prevent or treat thrombosis.

Otamixaban: Otamixaban is an investigational anticoagulant that was being studied for its potential use in acute coronary syndromes. Please note that its status may have changed since my last update in January 2022.

Lepirudin (Refludan): Lepirudin is an injectable direct thrombin inhibitor used in patients with heparin-induced thrombocytopenia (HIT) or other thrombotic disorders.

Drotrecogin alfa (Xigris): Drotrecogin alfa, also known as activated protein C (APC), was an injectable anticoagulant used in severe sepsis. However, it was withdrawn from the market due to limited clinical benefit.

Urokinase: Urokinase is an injectable thrombolytic agent used to dissolve blood clots in conditions like pulmonary embolism or acute arterial occlusion.

Streptokinase: Streptokinase is another thrombolytic agent used to dissolve blood clots, particularly in the context of acute myocardial infarction (heart attack).

Reteplase (Retavase): Reteplase is a thrombolytic agent used in the treatment of acute myocardial infarction to dissolve blood clots.

Alteplase (tPA, Activase): Alteplase is another thrombolytic agent used for the treatment of acute ischemic stroke, myocardial infarction, and pulmonary embolism.

Anistreplase (Eminase): Anistreplase is a thrombolytic agent used for the treatment of acute myocardial infarction.